Home›Stock Screener›Genpharmasec

Genpharmasec Share Price Today | Stock Price & Genpharmasec Share Screener

GENPHARMA Trading & Distributors
Live Share Price BSE
₹1.10
▲ 0.03 (2.80%)
2026-10-05 00:00:00

As of October 5, 2026, the live Genpharmasec share price (BSE: GENPHARMA) is ₹1.10, up 2.80% from the previous close, with shares trading between ₹1.07 and ₹1.10 in today's trading session, and a 52-week range of ₹0.78–₹1.78. Check Genpharmasec yearly highs lows for the annual price range and momentum. Use the Genpharmasec stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Genpharmasec opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹57 and net income of ₹1, with EBITDA of ₹3, an operating margin of 4.0% and a profit margin of 1.8%.

Genpharmasec Market Cap ₹60.96 Cr.
GENPHARMA P/E Ratio (TTM) -107.00
Genpharmasec P/B Ratio 0.89
EPS (TTM) ₹0.01
Dividend Yield -
Debt to Equity 0.31
GENPHARMA 52 Week High ₹1.78
Genpharmasec 52 Week Low ₹0.78
Operating Margin 4.00%
Profit Margin 1.75%
GENPHARMA Revenue (TTM) ₹57.00
EBITDA ₹3.00
Net Income ₹1.00
Total Assets ₹138.00
Total Equity ₹66.00

Genpharmasec Share Price Chart

Track the current stock price of Genpharmasec with an interactive chart. Analyse GENPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Genpharmasec stock quote in one place.

The quote of ₹1.10 sits between the 52-week low of ₹0.78 and the 52-week high of ₹1.78, and the latest session moved 2.80% from the previous close.

Genpharmasec Company Profile - Fundamental Screener

Screen Genpharmasec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GENPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Commercial Services sector and the Trading & Distributors industry, and it trades under ISIN INE861N01036.

Company Details

Classification

Sector Commercial Services
Industry Trading & Distributors
Sub-Sector Trading & Distributors
Segment E

Identifiers and Leadership

ISIN INE861N01036

Genpharmasec Balance Sheet Screener

Screen GENPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹138, up from ₹80 in 2025.

Latest statistics put total assets at ₹138 and shareholder funds at ₹66, with a leverage ratio of 0.31.

Item 2026 2025 2024 2023

Assets

Total Assets 138 80 71 20
Current Assets 81 26 41 19
Fixed Assets 41 8 1 0

Liabilities

Total Liabilities 0 0 0 0
Current Liabilities 26 5 4 3
Non-Current Liabilities 0 0 0 0

Shareholders' Equity

Total Equity 66 65 65 15
Share Capital 55 55 55 28
Reserves & Surplus 11 10 9 -12

Genpharmasec Income Statement Screener - Profit & Revenue Analysis

Screen Genpharmasec income statement and profit fundamentals. Analyze GENPHARMA quarterly results. Genpharmasec reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹57 and net profit was ₹1, equal to earnings per unit of ₹0.02, at an operating margin of 4%.

In that period expenses were ₹53, interest cost ₹1 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹50 and net profit of ₹0.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 57 50 15 13 33 41 11 6 7 9 6 6 8 7
Expenses 53 49 15 11 33 41 10 5 6 8 6 6 8 6

Operating Costs and Margins

EBITDA 3 1 0 2 0 0 0 1 1 2 0 0 0 0
Operating Profit % 4.00% 2.00% -7.00% 8.00% -1.00% -3.00% 0.00% 4.00% 2.00% 8.00% 3.00% 0.00% -1.00% 0.00%
Depreciation 1 1 0 0 1 1 0 0 0 0 0 0 0 0
Interest 1 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 2 0 0 1 -1 -1 0 1 1 1 0 0 0 0
Tax 1 0 0 0 0 -1 0 0 0 1 -1 0 0 0
Net Profit 1 0 0 1 -1 -1 0 0 1 1 1 0 0 0
EPS 0.02 0.00 -0.01 0.02 -0.02 -0.02 0.01 0.01 0.01 0.01 0.04 0.00 0.00 0.00

Genpharmasec Cash Flow Screener - Liquidity Fundamentals

Screen GENPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹18.

Over the same period, investing activities provided ₹13 and financing activities provided ₹4.

Item 2026-March 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities -18 3 -3 -3
Investing Activities 13 -4 -28 0

Financing and Net Cash

Financing Activities 4 -1 48 3
Net Cash Flow 0 -3 17 0

Genpharmasec Shareholding Pattern Screener

See Genpharmasec shareholding pattern with promoter, FII, and DII holdings. Check Genpharmasec promoter holding and ownership changes for GENPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 29.98%, foreign institutions 0.00%, domestic institutions 0.00% and the public 61.86%, spread across 102,252 shareholders.

The shareholder count was 102,252 in 2026-Mar, compared with 101,134 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Feb 2024-Mar

Promoter Holding

Promoter Holding 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 61.86% 61.84% 59.94% 60.03% 60.19% 62.00% 52.78% 56.17%
Other Holding 8.16% 8.18% 10.08% 9.99% 9.83% 8.02% 17.24% 13.84%
Shareholder Count 102,252 101,134 109,080 107,602 105,804 104,021 105,693 108,137

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Genpharmasec. Genpharmasec dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Genpharmasec.

Genpharmasec Stock Index Membership - Nifty & Sensex

See which indices include Genpharmasec stock. Check GENPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Genpharmasec is not part of any tracked indices.
Only major market indices are tracked in our system.

Genpharmasec Market Events Screener - Corporate Actions

Get Genpharmasec corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Genpharmasec stock events that may affect GENPHARMA share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 21, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA -4.24%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 0.96%
2026-05-21 2026-05-21 Quarterly Result Announcement NA -3.36%
2026-02-09 2026-02-09 Quarterly Result Announcement NA -2.59%
2025-11-06 2025-11-06 Quarterly Result Announcement NA -11.30%
2025-09-29 2025-09-29 Annual General Meeting NA 1.04%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 0.00%
2025-05-21 2025-05-21 Quarterly Result Announcement NA 9.27%
2025-02-10 2025-02-10 Quarterly Result Announcement NA -11.46%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -6.05%
2024-07-23 2024-07-23 Annual General Meeting NA 10.55%
2024-01-09 2024-01-09 Rights 1:1 82.23%
2021-09-06 2021-09-06 Change Of Name NA 0.00%

Genpharmasec Competitors Screener - Peer Stocks Comparison

Screen GENPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Commercial Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Redington 32,268 20.66 119,347 19.87% 1,284 64.41
MMTC 8,450 18.86 181 -31.28% 387 29.33
MSTC 4,884 21.18 453 16.90% 218 43.69
Ravindra Energy 2,863 48.75 576 94.53% 79 38.32
Vintage Coffee & Beverages 2,675 33.26 553 76.98% 72 59.10
BN Agrochem 2,331 131.43 874 137.94% 34 64.96
Creative Newtech 1,610 22.00 2,718 50.85% 70 42.72
Elitecon International 1,197 6.72 5,075 820.35% 185 28.88
TCC Concept 1,119 16.64 206 130.25% 65 42.96
Pervasive Commodities 1,112 44 43.56% 0 100.00

Genpharmasec Company Announcements - News & Reports Screener

Screen GENPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 1, 2026 and September 30, 2026.

Date Update Actions
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-27 Closure of Trading Window -
2026-09-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-09-07 Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29 2026. -
2026-09-02 Intimation Of Book Closure For The Purpose Of AGM -
2026-09-02 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-02 Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday 02Nd September 2026. -
2026-09-02 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-31 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-28 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 02Nd September 2026. -
2026-08-13 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-11 Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June 2026. -
2026-08-11 Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2026. -
2026-08-11 Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday 11Th August 2026. -
2026-08-03 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 11Th August 2026. -
2026-07-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1.10, within a 52-week range of ₹0.78 to ₹1.78. The P/E ratio is -107.00 and the P/B ratio is 0.89, with earnings per unit of ₹0.01. Market capitalisation stands at ₹60.96 Cr. The company operates in the Commercial Services sector, in the Trading & Distributors industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 4 balance sheet periods, 14 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.